Patents by Inventor William Tepp

William Tepp has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BOTULINUM NEUROTOXIN A SUBTYPE 6 AND PHARMACOLOGICAL METHODS OF USE
    Publication number: 20200330563
    Abstract: The invention is related to preparation of botulinum toxin A6 and methods of use.
    Type: Application
    Filed: October 11, 2018
    Publication date: October 22, 2020
    Inventors: Eric Johnson, Molly Moritz, Sabine Pellett, Marite Bradshaw, William Tepp
  • Purification, characterization, and use of Clostridium botulinum neurotoxin BoNT/A3
    Patent number: 9498521
    Abstract: Preparations of Clostridium botulinum neurotoxin BoNT/A3 and methods for using such preparations for treating a patient having a symptom in need of botulinum toxin therapy are provided herein.
    Type: Grant
    Filed: September 26, 2012
    Date of Patent: November 22, 2016
    Assignee: WISCONSIN ALUMNI RESEARCH FOUNDATION
    Inventors: Eric Johnson, William Tepp, Guangyun Lin
  • Purification, Characterization, and Use of Clostridium Botulinum Neurotoxin BoNT/A3
    Publication number: 20150250861
    Abstract: Preparations of Clostridium botulinum neurotoxin BoNT/A3 and methods for using such preparations for treating a patient having a symptom in need of botulinum toxin therapy are provided herein.
    Type: Application
    Filed: September 26, 2012
    Publication date: September 10, 2015
    Inventors: Eric Johnson, William Tepp, Guangyun Lin
  • Escherichia coli-derived vaccine and therapy against botulism
    Publication number: 20070059326
    Abstract: A method of producing botulinum toxin C-terminal receptor binding domain (HCR) is disclosed. The one embodiment, the method comprises the steps of (a) preparing E. coli transformed with an expression vector comprising DNA encoding HCR protein, (b) inducing expression of the HCR protein at a reduced temperature in a culture media, and (c) purifying the HCR protein via extraction, wherein the extraction comprises a clarification by centrifugation and a filtration, wherein the purified HCR protein is at least 10 mg/L of culture medium.
    Type: Application
    Filed: November 30, 2005
    Publication date: March 15, 2007
    Inventors: Michael Baldwin, Marite Bradshaw, William Tepp, Eric Johnson, Joseph Barbieri, Christina Pier